Institutional investors hold a majority ownership of AGN through the 90.22% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Generic industry. Last, during the quarter ended December 2017, these large investors purchased a net $1.3 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
SOUTHEASTERN ASSET MANAGEMENT, I... Bought 2.3 Million shares of Allergan plc
WELLINGTON MANAGEMENT CO. LLP Bought 1.9 Million shares of Allergan plc
APPALOOSA LP Bought 1.6 Million shares of Allergan plc